
LCINQ
Healthcare · Drug Manufacturers - Specialty & Generic
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| May 15, 2023 | After the close | -1.56 | -9.84 | -530.8% |
| Feb 2, 2023 | Time not confirmed | — | -3.53 | — |
| Nov 3, 2022 | Time not confirmed | — | -2.74 | — |
| Aug 25, 2022 | Time not confirmed | — | -9.19 | — |
| May 5, 2022 | Time not confirmed | — | -3.45 | — |
| Feb 4, 2022 | Time not confirmed | — | -8.04 | — |
| Nov 4, 2021 | Time not confirmed | — | -2.24 | — |
| Aug 26, 2021 | Time not confirmed | — | -17.99 | — |
| May 6, 2021 | Time not confirmed | — | -0.72 | — |
| Feb 4, 2021 | Time not confirmed | — | -17.44 | — |
| Nov 5, 2020 | Time not confirmed | — | -0.67 | — |
| Aug 27, 2020 | Time not confirmed | — | -1.00 | — |
| May 7, 2020 | Time not confirmed | — | -1.71 | — |
Lannett Company, Inc. develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products in the United States. The company offers solid oral and extended release, topical, liquid, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, nasal, patch, foam, buccal, sublingual, suspensions, soft gel, injectable,…
| Feb 6, 2020 |
| Time not confirmed |
| — |
| 0.50 |
| — |
| Nov 7, 2019 | Time not confirmed | — | -1.27 | — |
| Aug 28, 2019 | Time not confirmed | — | -0.20 | — |
| May 7, 2019 | Time not confirmed | — | 1.08 | — |
| Feb 7, 2019 | Time not confirmed | — | 1.26 | — |
| Nov 8, 2018 | Time not confirmed | — | -30.60 | — |
| Aug 29, 2018 | Time not confirmed | — | -1.22 | — |
| May 8, 2018 | Time not confirmed | — | 1.33 | — |
| Feb 8, 2018 | Time not confirmed | — | 1.46 | — |